Investigators developed an enzyme-responsive injectable hydrogel to overcome the limitations of therapeutic enema. The hydrogels possess two major advantages, which were being exploited for therapeutic drug delivery in ulcerative colitis: prolonged retention and enzyme responsiveness.
[ACS Biomaterials Science & Engineering]